Biomarker and Diagnostics Strategy

This is where precision medicine starts – whether you’re trying to find the right tools to uncover new biomarkers, identify CDx partners, launch an IVD, or understand how your assay will fit into the clinical journey, DeciBio has you covered. Nobody knows biomarkers and CDx better than DeciBio.

Our Experts

Andrew Aijian

Stephane Budel

David Cavanaugh

David Cavanaugh

Schedule a Call

Related Client Results

All Client Results

Pharma & Biotech

Biopharma Genomic Testing Market Research

A diagnostic company wanted to assess the current and expected future landscapes for biopharma oncology genomics research and Dx / CDx

Voice-of-Customer Research

Sequencing Technology Go-to-Market Strategy

A research tools start-up enlisted DeciBio to support their go-to-market strategy and activities for their novel sequencing technology by conducting pricing voice-of-customer research and evaluating potential pricing strategies

Voice-of-Customer Research

Go-to-Market Strategy

Pricing Strategy

Competitive Analysis

VOC research, competitive assessment for a novel multi-omic technology

A ~$100M research tools and diagnostic company wanted to understand key applications and revenue potential of their novel technology to inform a go / no-go development decision

Pricing Strategy

Voice-of-Customer Research

Competitive Analysis

Market Landscaping and Sizing

Novel Technology Commercialization

Pharma & Biotech

Cell and Gene Therapy Services Landscape Assessment

A top-10 scientific service provider wanted to quantify the size of the CGT services market and understand trends within

No items found.

Financial Services

PE-Backed Life Sciences Tools Platform Development

A leading private equity firm and management team sought out DeciBio as a strategic partner to advise on the life sciences market and perform due-diligences in support of the development of a novel life sciences tools platform

Voice-of-Customer Research

Customer Segmentation

Pricing Strategy

Due Diligence

Competitive Analysis

Financial Services

CDD on Novel Handheld Diagnostic Device Manufacturer

A global healthcare investment firm wanted to perform a commercial due diligence (CDD) prior to investment in a company producing a novel handheld diagnostic.

Voice-of-Customer Research

KOL Identification

Pricing Strategy

Revenue Projection

Due Diligence

Precision Medicine is evolving at a rapid pace

Discover how we can help